1-2 of 2
Thomas Duell
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeted Natural Killer Cell–Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical Trial

Gabriele Multhoff, Sophie Seier, Stefan Stangl, Wolfgang Sievert, Maxim Shevtsov, Caroline Werner, A. Graham Pockley, Christiane Blankenstein, Martin Hildebrandt, Robert Offner, Norbert Ahrens, Konrad Kokowski, Matthias Hautmann, Claus Rödel, Rainer Fietkau, Dorota Lubgan, Rudolf Huber, Hubert Hautmann, Thomas Duell, Michael Molls, Hanno Specht, Bernhard Haller, Michal Devecka, Andreas Sauter, Stephanie E. Combs
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2020) 26 (20): 5368–5379.
https://doi.org/10.1158/1078-0432.CCR-20-1141
Published: 15 October 2020
View article titled, Targeted Natural Killer Cell–Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical Trial
Open the PDF for Targeted Natural Killer Cell–Based Adoptive Immunotherapy for the Treatment of Patients with NSCLC after Radiochemotherapy: A Randomized Phase II Clinical Trial in another window
Includes: Supplementary data
Journal Articles

Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in Monitoring First-Line Chemotherapy of Small Cell Lung Cancer

Stefan Holdenrieder, Joachim von Pawel, Elke Dankelmann, Thomas Duell, Bernhard Faderl, Andreas Markus, Maria Siakavara, Horst Wagner, Knut Feldmann, Harald Hoffmann, Hannelore Raith, Dorothea Nagel, Petra Stieber
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (23): 7813–7821.
https://doi.org/10.1158/1078-0432.CCR-08-0678
Published: 01 December 2008
View article titled, Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in Monitoring First-Line Chemotherapy of Small Cell Lung Cancer
Open the PDF for Nucleosomes, ProGRP, NSE, CYFRA 21-1, and CEA in Monitoring First-Line Chemotherapy of Small Cell Lung Cancer in another window